Scalable and accurate rare-variant association tests for whole genome sequencing time-to-event analysis in large biobanks

Proc Natl Acad Sci U S A. 2026 Mar 3;123(9):e2525288123. doi: 10.1073/pnas.2525288123. Epub 2026 Feb 27.

Abstract

Whole genome sequencing (WGS) studies in large biobanks provide an unprecedented opportunity to study the rare-variant (RV) effects on the natural history of human diseases by analyzing censored time-to-event (TTE) phenotypes, such as age at disease diagnosis, disease progression, and lifespan. Unlike existing methods developed for continuous and categorical phenotypes, rare-variant association tests (RVATs) for TTE phenotypes in large biobanks face several major challenges, including heavy censoring, cryptic relatedness, and population structure. We introduce GATE-STAAR (Genetic Analysis of Time-to-Event phenotypes via the variant-Set Test for Association using Annotation infoRmation), a powerful and computationally efficient frailty model framework for RVATs of TTE phenotypes in large biobanks. GATE-STAAR accounts for high censoring rates, cryptic relatedness, and population structure in large biobanks, while incorporating multifaceted variant functional annotations to improve power and result interpretability. We propose a rare-variant saddlepoint approximation method to effectively address heavy censoring in WGS TTE analysis. We demonstrate through extensive simulations that GATE-STAAR is powerful while maintaining proper control of type I error rates. We apply GATE-STAAR to analyze the WGS data of approximately 400,000 UK Biobank participants of white British ancestry across a variety of TTE phenotypes, and validate the findings using participants of European ancestry from the All of Us Research Program. These analyses uncover RV associations with age at diagnosis of a range of diseases.

Keywords: rare variants; saddlepoint approximation; time-to-event analysis; whole genome sequencing.

MeSH terms

  • Biological Specimen Banks*
  • Genetic Variation*
  • Genome, Human
  • Genome-Wide Association Study* / methods
  • Humans
  • Phenotype
  • Whole Genome Sequencing* / methods